Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 7, 2000, Pages 640-644

  Lavit, Michel ^a,b   Saivin, Sylvie ^a,b   Boudra, Hamid ^a,b   Michel, Frank ^a   Martin, Arnaud ^c   Cahiez, Gérard ^c   Labaune, Jean Pierre ^d   Chomard, Jean Marie ^e   Houin, Georges ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Ecole Superieure de Chimie Organique et Minerale   (France)

^d Rivopharm SA   (Switzerland)

^e Direction EuroGalena   (France)

Author keywords

CAS 34140 59 5; CAS 39133 31 8; Desmethyl trimebutine, determination in plasma, HPLC; Trimebutine, determination in plasma, HPLC

Indexed keywords

DRUG METABOLITE; PROCAINE; TRIMEBUTINE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; QUALITY CONTROL; VALIDATION PROCESS;

EID: 0033943047     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300264     Document Type: Article

References (14)

1. [1] Fraitag, B., Hostein, J., Pascaud, X. et al., Trimebutine. Pharmacologie, acquisitions récentes sur son mode d'action, résultats thérapeutiques. Gastroenterol. Clin. Biol. 16, 413 (1992)
2. [2] Fioramonti, J., Fargeas, M. J., Bueno, L., The involvement of opiate receptors in the efffects of trimebutine on intestinal motility in the conscious dog. J. Pharm. Pharmacol. 36, 618 (1984)
3. [3] Pascaud, X., Roman, F, Petoux, F. et al., Implication des récepteurs opiacés dans le mode d'action de la trimébutine. Gastroenterol. Clin. Biol. 11, 77 (1987)
4. [4] Allescher, H. D., Ahmad, S., Classen, M. et al., Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum. J. Pharmacol. Exp. Ther. 257, 836 (1991)
5. [5] Roman, F., Pascaud, X., Taylor, J. E. et al., Interactions of trimebutine with guinea-pig opioid receptors. J. Pharm. Pharmacol. 39, 404 (1987)
6. [6] Poitras, P., Honde, C., Havrankova, J., Effect of trimebutine on intestinal motility and plasma motilin in the dog. Am. J. Physiol. 251, 349 (1986)
7. [7] Yoshikawa, M., Endo, H., Ohnogi, Y. et al., Absorption, distribution and excretion of trimebutine maleate in rats, mice and dogs. Pharmacometrics 24, 289 (1982)
8. [8] Collins, S. M., Daniel, E. E., Opiate modulation of gastrointestinal motility and the actions of trimebutine. Can. J. Gastroenterol. 5, 185 (1991)
9. [9] Diamant, N., Enkephalinergic control of gastrointestinal motility: from "gut-brain" to trimebutine. Can. J. Gastroenterol. 1, 41 (1987)
10. [10] Bueno, L., Honde, C., Pascaud, X. et al., Effects of orally vs. parenterally administered trimebutine on gastrointestinal and colonic motility in dogs. Gastroenterol. Clin. Biol. 11, 90 (1987)
11. [11] Astier, A., Deutsch, A. M., Quantitative high-performance liquid chromatographic determination of antispasmodic trimebutine in human plasma: pharmacokinetic studies after intravenous administration in humans. J. Chromatogr. 224, 149 (1981)
12. [12] Shah, V. P., Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur. J. Drug Metab. Pharmacokinet. 16, 249 (1991)
13. [13] Martin, A., Figadère, B., Saivin, S. et al., Synthesis of Methylamino-2-phenyl-2-butyl-3,4,5-trimethoxybenzoate, the main bioactive metabolite of trimebutine maleate. Arzneim.-Forsch./Drug Res. 50 (I), 544(2000)
14. [14] Saivin, S., Lavit, M., Michel, F. et al., Pharmacokinetics and bioequivalence of two trimebutine formulations in healthy volunteers using desmethyl-trimebutine level. Arzneim.-Forsch./Drug Res. 50 (II), in press (2000)